Search

everythinglearnresearchcommunity

for

Search:↓

Congenital triangular alopecia can occur outside the typical fronto-temporal region.

Chronic stress and high cortisol levels can cause hair loss by disrupting hair growth.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

A rare hair regrowth pattern can occur in some people with alopecia areata.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Temporal triangular alopecia is a non-scarring hair loss in children, often linked to other health conditions.

Squaric acid dibutylester effectively treats alopecia areata.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

88% phenol is effective for treating alopecia areata.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Nanoparticle drug delivery could improve alopecia areata treatment.

Congenital triangular alopecia is a hair loss condition present from birth or early childhood with no effective treatment needed.

Dental care may help improve hair loss in alopecia patients.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

Janus kinase inhibitors are effective and safe for treating alopecia areata.

Alopecia areata causes patchy hair loss and is often treated with corticosteroids.

Children with alopecia areata need supportive care and off-label treatments due to a lack of approved options.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

CXCL12 can both help and harm hair growth in alopecia areata.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Early intervention and patient education are crucial for managing alopecia areata.